Avita Medical Inc.

RCEL Healthcare Medical Devices

Avita Medical Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71.6 million, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 17.8%, EPS grew 33.8%, free cash flow grew 66.5% and total debt rose 10.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

13.04 0.37 −2.76%
Market cap
$333.1M
P/E
0.0×
Fwd P/E
−3.6×
Dividend yield
—
F-score
3/9
Altman Z
−11.96
Beneish M
−4.09
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Jun '21 Dec '20 Jun '20 Dec '19 Jun '19
Piotroski F-Score
3 3 2 — — — — — — —
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
0.07 0.26 0.34 0.23 1.07 0.87 1.12 0.00 0.00 0.00
Altman Z-Score
(11.96) (7.16) (3.15) (2.98) 13.90 (0.43) 16.65 (1.94) 1,404.38 42.97
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
(32.20) (16.38) (4.60) 1.17 9.47 11.12 (2.12) 2.05 (23.16) (12.52)
Beneish M-Score
(4.09) (2.03) (3.01) 0.20 — — — — — —
P/Operating CF
(0.88) (2.05) (1.58) (2.35) 1.96 (6.38) (3.54) (5.24) (9.98) 0.00
P/B ratio
0.00 3.68 0.35 0.10 0.14 0.22 0.34 0.43 0.50 0.00
Price to Tangible BV
0.00 0.00 0.35 0.10 0.14 0.22 0.34 0.43 0.50 0.00
EV/Sales
0.99 0.37 (0.62) (2.04) (4.98) (2.85) (2.11) 0.00 0.00 0.00
EV/EBITDA
0.00 0.00 0.93 2.70 4.95 5.36 1.16 0.00 0.00 0.00
EV/Operating CF
(2.28) (0.49) 0.82 3.69 12.64 26.22 2.82 3.33 2.44 0.45
EV/FCF
(2.15) (0.41) 0.79 3.57 12.34 22.23 2.64 3.29 2.34 0.43
Quick Ratio
0.44 2.36 7.33 7.83 16.08 16.01 9.90 9.89 5.09 5.09
Current Ratio
0.57 2.83 7.88 8.18 16.42 16.42 10.17 10.17 5.50 5.50
Net Debt/EBITDA
(0.60) (0.11) 1.47 3.01 4.03 4.30 1.56 1.78 0.65 0.83
Debt/Assets
76.22% 53.00% 35.66% 0.93% 1.26% 0.00% 2.98% 0.00% 0.15% 0.15%
Debt/Equity
(2.58) 9.39 0.81 0.01 0.01 0.00 0.03 0.00 0.00 0.00
Asset Turnover
1.05 0.67 0.48 0.31 0.23 0.28 0.17 0.26 0.21 0.25
Operating CF/Net income
0.64 0.79 1.07 0.72 0.97 0.97 0.54 0.54 0.78 0.79
Capex/Depreciation
(0.70) (8.14) (2.19) (0.92) (0.09) (1.64) 0.00 (1.82) 0.00 (4.77)
Interest Coverage
(8.71) (10.53) (29.90) (1,663.31) (3,364.12) (1,205.59) (2,824.55) (1,272.52) (192.77) (920.36)
ROE
799.72% (230.96%) (52.89%) (26.61%) (22.98%) (28.27%) (58.05%) (90.09%) (117.92%) (138.34%)
ROA
(71.40%) (64.64%) (33.71%) (23.83%) (21.18%) (25.57%) (50.97%) (77.66%) (96.61%) (114.36%)
ROIC
(334.18%) (324.79%) 0.00% (263.35%) (142.98%) (352.10%) 0.00% 0.00% 0.00% (1,478.09%)
Return on Tangible Assets
261.83% (131.98%) (38.17%) (34.20%) (22.74%) (23.04%) (56.50%) (58.34%) (118.91%) (114.83%)
Average Days of Receivables
46.31 66.95 56.01 46.80 98.43 92.44 64.16 62.24 138.52 141.17
Research and Development Expense of Revenue
29.10% 31.69% 41.52% 40.26% 50.69% 50.69% 59.32% 64.25% 186.39% 186.39%
Selling, General and Administrative Expense of Revenue
112.43% 142.24% 130.88% 131.44% 126.78% 126.78% 346.59% 341.66% 462.84% 463.54%
Intangible Assets out of Total Assets
0.10 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01
Share Based Compensation of Revenue
13.29% 21.01% 16.72% 20.33% 12.27% 19.38% 0.00% 115.59% 0.00% 35.31%
Graham Net Nets
(7.81) (1.10) 2.41 9.17 5.41 4.37 2.77 2.20 1.90 0.00
Graham Number
96.85 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(1,011.00%) (373.39%) (205.63%) (330.73%) (118.44%) (91.83%) (149.45%) (21.84%) (12.64%) (18.40%)
Free Cash Flow Yield
(687.12%) (352.21%) (229.89%) (244.34%) (37.74%) (14.69%) (71.08%) (39.88%) (40.73%) 0.00%
Revenue per Share
51.41 49.65 39.58 27.54 1.29 25.78 0.70 14.05 0.02 0.43
Operating CF per Share
(22.39) (37.82) (30.00) (15.27) (1.14) (22.85) (1.12) (22.41) (0.08) (1.55)
Capex per Share
(1.18) (7.09) (1.09) (0.42) (0.01) (1.04) 0.00 (0.83) 0.00 (0.10)
Free Cash Flow per Share
(23.57) (44.91) (31.09) (15.69) (1.15) (23.88) (1.12) (23.25) (0.08) (1.65)
Cash per Share
13.05 27.73 70.29 63.47 4.89 97.86 3.64 72.75 0.08 1.64
Shareholders Equity per Share
(11.95) 3.48 38.72 67.79 5.10 102.02 3.57 71.33 0.08 1.71
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(11.95) 3.48 38.72 67.79 5.10 102.02 3.57 71.33 0.08 1.71
Free Cash Flow
(32.83) (58.11) (39.39) (19.61) (26.03) (27.07) (22.75) (23.59) (19.66) (20.94)
Working Capital
(27.19) 36.84 90.81 76.77 113.94 113.94 70.68 70.68 19.86 20.24
Capital Expenditures
(1.64) (9.17) (1.38) (0.52) (0.13) (1.17) (0.85) (0.85) (1.28) (1.28)
Net Current Asset Value
(37.55) (18.21) 41.42 73.93 111.48 111.48 68.33 68.33 19.39 20.20
EV/EBIT
0.00 0.00 0.91 2.64 4.83 3.14 0.86 0.00 0.00 0.00
Capex to Sales
0.02 0.14 0.03 0.02 0.00 0.04 0.00 0.06 0.00 0.23
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.27 0.11 0.34 0.47 0.49 0.49 0.26 0.34 0.21 0.20
Cash ROIC
(73.76%) (70.33%) (22.14%) (11.89%) (11.41%) (11.95%) (15.30%) (16.13%) (47.62%) (49.26%)
Accounts Receivable Turnover
6.86 6.60 8.28 5.60 3.82 5.90 5.78 6.31 2.61 1.79
Accounts Payable Turnover
1.68 1.80 2.29 1.97 1.91 1.60 0.69 1.24 0.54 0.57
Inventory Turnover
1.80 1.41 2.02 3.20 3.61 4.29 2.64 3.18 1.62 1.51
Average Days of Payables
255.59 252.62 177.95 181.38 191.43 191.43 531.97 531.97 143.27 1,211.09
Days of Inventory on Hand
197.59 291.75 262.54 128.39 101.05 101.05 138.12 138.12 223.14 227.39
Average Receivables
10.44 9.74 6.05 6.15 7.64 4.96 2.47 2.26 2.11 3.07
Average Payables
7.63 5.04 3.40 3.06 3.12 3.73 4.33 2.40 2.25 2.12
Average Inventory
7.10 6.43 3.86 1.89 1.65 1.39 1.13 0.93 0.75 0.81
Average Assets
68.05 95.68 104.95 111.88 125.50 103.98 82.46 54.12 26.03 21.64
Average Common Equity
(6.08) 26.78 66.90 100.20 115.66 94.03 72.40 46.65 21.32 17.89

Fold the line items

Columns are period end dates